|
OMIM |
Link |
Information gain |
01 |
|
MYMY1
|
[NCBI]
|
0.00363348
|
|
|
peripheral arterial occlusive disease 1
|
[NCBI]
|
0.00116675
|
|
|
sneddon syndrome
|
[NCBI]
|
0.000693453
|
|
|
GACI
|
[NCBI]
|
0.000421036
|
|
|
fibromuscular dysplasia of arteries
|
[NCBI]
|
0.000351229
|
|
|
VEGF
|
[NCBI]
|
0.000272943
|
|
|
arterial occlusive disease, progressive, with hypertension, heart defects, bone fragility, and brachysyndactyly
|
[NCBI]
|
0.000245357
|
|
|
SLE
|
[NCBI]
|
0.000196654
|
|
|
PXE
|
[NCBI]
|
0.000111044
|
|
|
MPO
|
[NCBI]
|
0.000106814
|
|
|
temporal arteritis
|
[NCBI]
|
7.85391e-05
|
|
|
GDNF
|
[NCBI]
|
7.78641e-05
|
|
|
homocystinuria
|
[NCBI]
|
7.66198e-05
|
|
|
MAP2
|
[NCBI]
|
7.21069e-05
|
|
|
aspirin resistance
|
[NCBI]
|
7.16763e-05
|
|
|
PROS1
|
[NCBI]
|
6.71555e-05
|
|
|
WBS
|
[NCBI]
|
6.55733e-05
|
|
|
TFPI
|
[NCBI]
|
6.32843e-05
|
|
|
ELN
|
[NCBI]
|
5.45848e-05
|
|
|
MTR
|
[NCBI]
|
5.30078e-05
|
|
|
CGL2
|
[NCBI]
|
5.22232e-05
|
|
|
homocysteinemia
|
[NCBI]
|
5.16725e-05
|
|
|
RA
|
[NCBI]
|
5.09258e-05
|
|
|
F3
|
[NCBI]
|
4.80785e-05
|
|
|
CADASIL
|
[NCBI]
|
4.78495e-05
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
4.74312e-05
|
|
|
NF1
|
[NCBI]
|
4.51433e-05
|
|
|
sickle cell anemia
|
[NCBI]
|
4.13638e-05
|
|
|
ANKRD1
|
[NCBI]
|
3.64731e-05
|
|
|
ASL
|
[NCBI]
|
3.56519e-05
|
|
|
SVAS
|
[NCBI]
|
3.54452e-05
|
|
|
HGFAC
|
[NCBI]
|
3.12869e-05
|
|
|
GFAP
|
[NCBI]
|
3.09475e-05
|
|
|
CP
|
[NCBI]
|
2.93954e-05
|
|
|
AQP4
|
[NCBI]
|
2.60211e-05
|
|
|
ACE
|
[NCBI]
|
2.57303e-05
|
|
|
PROCR
|
[NCBI]
|
2.5461e-05
|
|
|
COL3A1
|
[NCBI]
|
2.22703e-05
|
|
|
APOA1
|
[NCBI]
|
2.18929e-05
|
|
|
ASS
|
[NCBI]
|
1.906e-05
|
|
|
HGF
|
[NCBI]
|
1.89806e-05
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
1.59232e-05
|
|
|
CDK5
|
[NCBI]
|
1.52911e-05
|
|
|
PCNA
|
[NCBI]
|
1.35751e-05
|
|
|
PLG
|
[NCBI]
|
1.23958e-05
|
|
|
PTH
|
[NCBI]
|
1.04187e-05
|
|
|
ADA
|
[NCBI]
|
8.5788e-06
|
|
|
EGFR
|
[NCBI]
|
7.67887e-06
|
|
|
PWS
|
[NCBI]
|
6.25829e-06
|
|
|
HP
|
[NCBI]
|
6.07675e-06
|
|
|
PRL
|
[NCBI]
|
4.37201e-06
|
|
|
EGF
|
[NCBI]
|
4.02605e-06
|
|
|
TH
|
[NCBI]
|
3.32573e-06
|
|
|
TNF
|
[NCBI]
|
1.55999e-06
|
|
|
APOE
|
[NCBI]
|
1.3616e-06
|
|
|
AVP
|
[NCBI]
|
7.76785e-07
|
|
|
CRH
|
[NCBI]
|
1.70275e-07
|
|
|
EPO
|
[NCBI]
|
4.56021e-08
|
|
|
NGFB
|
[NCBI]
|
2.61079e-08
|
|
|
BDNF
|
[NCBI]
|
1.66801e-08
|
|
|
CAT
|
[NCBI]
|
1.29479e-08
|
|